These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 30327437)

  • 1. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.
    Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327437
    [No Abstract]   [Full Text] [Related]  

  • 2. Protective humoral and CD4
    Yu W; Yao D; Yu S; Wang X; Li X; Wang M; Liu S; Feng Z; Chen X; Li W; Wang L; Liu W; Ma J; Yu L; Tong C; Song B; Cui Y
    Sci Rep; 2018 Feb; 8(1):3580. PubMed ID: 29483570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.
    Zhang BZ; Hua YH; Yu B; Lau CC; Cai JP; Zheng SY; Yam WC; Kao RY; Sze KH; Zheng BJ; Yuen KY; Huang JD
    Infect Immun; 2015 Jan; 83(1):339-45. PubMed ID: 25368117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated protection against Staphylococcus aureus dermonecrosis and sepsis by a whole cell vaccine.
    Zhang F; Jun M; Ledue O; Herd M; Malley R; Lu YJ
    Vaccine; 2017 Jul; 35(31):3834-3843. PubMed ID: 28601365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
    Brady RA; Mocca CP; Prabhakara R; Plaut RD; Shirtliff ME; Merkel TJ; Burns DL
    PLoS One; 2013; 8(4):e63040. PubMed ID: 23658662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Vaccines for
    Dupont CD; Scully IL; Zimnisky RM; Monian B; Rossitto CP; O'Connell EB; Jansen KU; Anderson AS; Love JC
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135219
    [No Abstract]   [Full Text] [Related]  

  • 8. Harnessing antifungal immunity in pursuit of a Staphylococcus aureus vaccine strategy.
    Paterson MJ; Caldera JR; Nguyen C; Sharma P; Castro AM; Kolar SL; Tsai CM; Limon JJ; Becker CA; Martins GA; Liu GY; Underhill DM
    PLoS Pathog; 2020 Aug; 16(8):e1008733. PubMed ID: 32817694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines targeting Staphylococcus aureus skin and bloodstream infections require different composition.
    Luna BM; Nielsen TB; Cheng B; Pantapalangkoor P; Yan J; Boyle-Vavra S; Bruhn KW; Montgomery C; Spellberg B; Daum R
    PLoS One; 2019; 14(6):e0217439. PubMed ID: 31181086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role and plasticity of Th1 and Th17 responses in immunity to
    Ferraro A; Buonocore SM; Auquier P; Nicolas I; Wallemacq H; Boutriau D; van der Most RG
    Hum Vaccin Immunother; 2019; 15(12):2980-2992. PubMed ID: 31149870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity.
    Choi SJ; Kim MH; Jeon J; Kim OY; Choi Y; Seo J; Hong SW; Lee WH; Jeon SG; Gho YS; Jee YK; Kim YK
    PLoS One; 2015; 10(9):e0136021. PubMed ID: 26333035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus.
    Bagnoli F; Fontana MR; Soldaini E; Mishra RP; Fiaschi L; Cartocci E; Nardi-Dei V; Ruggiero P; Nosari S; De Falco MG; Lofano G; Marchi S; Galletti B; Mariotti P; Bacconi M; Torre A; Maccari S; Scarselli M; Rinaudo CD; Inoshima N; Savino S; Mori E; Rossi-Paccani S; Baudner B; Pallaoro M; Swennen E; Petracca R; Brettoni C; Liberatori S; Norais N; Monaci E; Bubeck Wardenburg J; Schneewind O; O'Hagan DT; Valiante NM; Bensi G; Bertholet S; De Gregorio E; Rappuoli R; Grandi G
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3680-5. PubMed ID: 25775551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Master mechanisms of Staphylococcus aureus: consider its excellent protective mechanisms hindering vaccine development!
    Zhang X; Marichannegowda MH; Rakesh KP; Qin HL
    Microbiol Res; 2018; 212-213():59-66. PubMed ID: 29853168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17A.
    Mancini F; Monaci E; Lofano G; Torre A; Bacconi M; Tavarini S; Sammicheli C; Arcidiacono L; Galletti B; Laera D; Pallaoro M; Tuscano G; Fontana MR; Bensi G; Grandi G; Rossi-Paccani S; Nuti S; Rappuoli R; De Gregorio E; Bagnoli F; Soldaini E; Bertholet S
    PLoS One; 2016; 11(1):e0147767. PubMed ID: 26812180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitope-based immunoinformatics study of a novel Hla-MntC-SACOL0723 fusion protein from Staphylococcus aureus: Induction of multi-pattern immune responses.
    Ahmadi K; Pouladfar G; Kalani M; Faezi S; Pourmand MR; Hasanzadeh S; Mafakher L; Aslani MM; Mahdavi M
    Mol Immunol; 2019 Oct; 114():88-99. PubMed ID: 31351414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broad and Effective Protection against Staphylococcus aureus Is Elicited by a Multivalent Vaccine Formulated with Novel Antigens.
    Deng J; Wang X; Zhang BZ; Gao P; Lin Q; Kao RY; Gustafsson K; Yuen KY; Huang JD
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31484738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection.
    Cheng BL; Nielsen TB; Pantapalangkoor P; Zhao F; Lee JC; Montgomery CP; Luna B; Spellberg B; Daum RS
    Hum Vaccin Immunother; 2017 Jul; 13(7):1609-1614. PubMed ID: 28422567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
    Adhikari RP; Thompson CD; Aman MJ; Lee JC
    Vaccine; 2016 Dec; 34(50):6402-6407. PubMed ID: 27847174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a future for a Staphylococcus aureus vaccine?
    Proctor RA
    Vaccine; 2012 Apr; 30(19):2921-7. PubMed ID: 22115633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models.
    Yang L; Cai C; Feng Q; Shi Y; Zuo Q; Yang H; Jing H; Wei C; Zhuang Y; Zou Q; Zeng H
    Sci Rep; 2016 Feb; 6():20929. PubMed ID: 26865417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.